Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Kidney problems news

Show

From To
Infection with HIV associated with increased risk of dialysis and end-stage kidney disease

HIV infection increases the risk of kidney disease requiring renal replacement therapy or dialysis, according to Danish research published in the online edition of Nephrology Dialysis Transplantation.

Published
01 October 2013
By
Michael Carter
Dolutegravir shows good efficacy across broad range of patient groups

The new integrase inhibitor dolutegravir worked better than boosted darunavir for people starting HIV treatment for the first time, researchers reported last Thursday at the 53rd Interscience

Published
17 September 2013
By
Liz Highleyman
New tenofovir formulation works equally well with less effect on kidneys and bones

Tenofovir alafenamide (TAF), a new formulation that produces higher drug levels in cells but allows for lower dosing, was as effective as the current tenofovir disoproxil fumarate

Published
13 September 2013
By
Liz Highleyman
Loss of kidney function in older people with HIV underlines need for earlier treatment

Kidney function deteriorates more rapidly in older people with HIV than in age-matched controls in both untreated and treated people, suggesting that antiretroviral therapy should be

Published
10 September 2013
By
Michael Carter
Cleared HCV infection associated with increased risk of kidney disease in people with HIV

People living with HIV with previous hepatitis C virus (HCV) infection continue to have an increased risk of chronic kidney disease, results of a North American

Published
20 August 2013
By
Michael Carter
Sourasky announces world’s first kidney donation, transplant between live HIV carriers

The surgery, the first of its kind in the world between living patients, took place a a few months ago, the hospital said, and the recipient has returned to work and normal functioning.

Published
19 August 2013
From
Jerusalem Post
People With HIV Have High Rates of End-Stage Renal Disease

People with HIV have a rate of end-stage renal disease (ESRD) more than five times that of the general population,

Published
16 July 2013
From
AIDSMeds
Kidney problems linked to tenofovir use, improve with switch to abacavir

Indian people with HIV taking tenofovir had a higher rate of kidney impairment than westerners, according to a study presented at the 7th International AIDS Society Conference on

Published
10 July 2013
By
Liz Highleyman
Senate Approves Bill to Allow HIV+ Patients to Receive HIV+ Donor Organs

The U.S. Senate this week unanimously passed the HOPE Act, a bill that will make an exception to current law enabling people with HIV to receive organs for transplantation from another HIV positive individual. The measure now awaits approval from the House of Representatives.

Published
20 June 2013
From
HIVandhepatitis.com
New pro-drug tenofovir alafenamide appears equally effective but better tolerated

Tenofovir alafenamide fumarate or TAF (formerly GS-7340), a new pro-drug of the widely used NRTI tenofovir, reaches cells harbouring HIV more easily than the older tenofovir disoproxil

Published
07 March 2013
By
Liz Highleyman

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.